Silent ischaemic brain lesions related to atrial high rate episodes in patients with cardiac implantable electronic devices

Europace

Volumn 17, Issue 3, 2015, Pages 364-369

  Benezet Mazuecos, Juan ^a   Rubio, José Manuel ^a   Cortés, Marcelino ^a   Iglesias, José Antonio ^a   Calle, Soraya ^a   De La Vieja, Juan José ^a   Quiñones, Miguel Angel ^a   Sanchez Borque, Pepa ^a   De La Cruz, Elena ^a   Espejo, Adriana ^a   Farré, Jerónimo ^a  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

Author keywords

Atrial fibrillation; Atrial high rate episodes; Cardiac electronic devices; Computed tomography.; Silent ischaemic brain lesions

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT;

AGED; ANTICOAGULATION; ARTICLE; ATRIAL HIGH RATE EPISODE; BRAIN DAMAGE; BRAIN SCINTISCANNING; CARDIAC EQUIPMENT; CARDIAC IMPLANTABLE ELECTRONIC DEVICE; CARDIOVASCULAR PARAMETERS; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; ISCHEMIC BRAIN LESION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSIENT ISCHEMIC ATTACK; ARTIFICIAL HEART PACEMAKER; ASYMPTOMATIC DISEASE; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; ELECTROCARDIOGRAPHY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; ISCHEMIC ATTACK, TRANSIENT; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RADIOGRAPHY; STROKE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ASYMPTOMATIC DISEASES; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; INCIDENCE; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PACEMAKER, ARTIFICIAL; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; STROKE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84924358599     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euu267     Document Type: Article

References (22)

1. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham Study. N Engl J Med 1982;306:1018-22.
2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-8.
3. Savelieva I, Camm AJ. Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management. J Interv Card Electrophysiol 2000;4:369-82.
4. Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S et al. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. J Am Coll Cardiol 2007;50:2156-61.
5. Lin H-J,Wolf PA, Benjamin EJ, Belanger AJ, D'Agostino RB. Newly diagnosed atrial fibrillation and acute stroke: the Framingham Study. Stroke 1995;26:1527-30.
6. Feinberg WN, Seeger JF, Carmody RF, Anderson DC, Hart RG, Pearce LA. Asymptomatic cerebral infarction in patients with atrial fibrillation. Circulation 1988;19: 955-7.
7. PollakWM,Simmons JD, InterianAJr, Atapattu SA, Castellanos A, Myerburg RJ et al. Clinical utility of intraatrial pacemaker stored electrograms to diagnose atrial fibrillation and flutter. Pacing Clin Electrophysiol 2001;24:424-9.
8. Glotzer TV, Hellkamp AS, Zimmerman J, Sweeney MO, Yee R, Marinchak R et al.; MOST Investigators. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation 2003;107:1614-9.
9. Glotzer TV, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, Hilker C et al. The relationship between daily atrial tachyarrhytmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circulation Arrhythm Electrophysiol 2009;2:474-80.
10. Healey JS, Connolly SJ, Gold MR, IsraelCW, Van Gelder IC, CapucciAet al.; ASSERT Investigators. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012; 366:120-9.
11. Wilkoff BL, Auricchio A, Brugada J, Cowie M, Ellenbogen KA, Gillis AM et al. HRS/ EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. Europace 2008;10:707-25.
12. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace 2013;15:1070-118.
13. Nowak B. Pacemaker stored electrograms: teaching us what is really going on in our patients. Pacing Clin Electrophysiol 2002;25:838-49.
14. Seidl K, Meisel E, VanAgt E, Ottenhoff F, Hess M, Hauer B et al. Is the atrial high rate episode diagnostic feature reliable in detecting paroxysmal episodes of atrial tachyarrhythmias? Pacing Clin Electrophysiol 1998;21:694-700.
15. Capucci A, Santini M, Padeletti L, Gulizia M, Botto G, BorianiGet al. Monitored atrial fibrillation duration predicts arterial embolism events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemaker. J Am Coll Cardiol 2005;46:1913-20.
16. Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol 2007;6:611-9.
17. Ezekowitz MD, James KE, Nazarian SM, Davenport J, Broderick JP, Gupta SR et al. Silent cerebral infarction in patients with non rheumatic atrial fibrillation. Circulation 1995;92:2178-82.
18. Kobayashi A, Iguchi M, Shimizu S, Uchiyama S. Silent cerebral infarcts and cerebral white matter lesions in patients with non valvular atrial fibrillation. J Stroke Cerebrovasc Dis 2012;21:310-7.
19. Marfella R, Sasso FC, SiniscalchiM, Cirillo M, Paolisso P, Sardu C et al. Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients. J Am Coll Cardiol 2013;62:525-30.
20. January CT,Wann LS, Alpert JS, Calkins H, Cleveland JC Jr, Cigarroa JE et al. 2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 2014; Apr 10. [EPUB ahead of print]
21. Ip J,Waldo AL, Lip GY, Rothwell PM, Martin DT, Bersohn MM et al.; IMPACT Investigators. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: rationale, design, and clinical characteristics of the initially enrolled cohort the IMPACT study. Am Heart J 2009;158:364-70.
22. A Comparison of Apixaban Versus Aspirin for Preventing Stroke in Patients With Pacemakers (ARTESiA) ClinicalTrials.gov Identifier: NCT01938248. http:// clinicaltrials.gov/ct2/show/NCT01938248?term=Artesia&rank=1. (6 August 2014).